Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.

Identifieur interne : 000794 ( Main/Corpus ); précédent : 000793; suivant : 000795

The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.

Auteurs : Giovanna Liuzzo ; Carlo Patrono

Source :

RBID : pubmed:33219663
DOI: 10.1093/eurheartj/ehaa935
PubMed: 33219663
PubMed Central: PMC7717256

Links to Exploration step

pubmed:33219663

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.</title>
<author>
<name sortKey="Liuzzo, Giovanna" sort="Liuzzo, Giovanna" uniqKey="Liuzzo G" first="Giovanna" last="Liuzzo">Giovanna Liuzzo</name>
</author>
<author>
<name sortKey="Patrono, Carlo" sort="Patrono, Carlo" uniqKey="Patrono C" first="Carlo" last="Patrono">Carlo Patrono</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33219663</idno>
<idno type="pmid">33219663</idno>
<idno type="doi">10.1093/eurheartj/ehaa935</idno>
<idno type="pmc">PMC7717256</idno>
<idno type="wicri:Area/Main/Corpus">000794</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000794</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.</title>
<author>
<name sortKey="Liuzzo, Giovanna" sort="Liuzzo, Giovanna" uniqKey="Liuzzo G" first="Giovanna" last="Liuzzo">Giovanna Liuzzo</name>
</author>
<author>
<name sortKey="Patrono, Carlo" sort="Patrono, Carlo" uniqKey="Patrono C" first="Carlo" last="Patrono">Carlo Patrono</name>
</author>
</analytic>
<series>
<title level="j">European heart journal</title>
<idno type="eISSN">1522-9645</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">33219663</PMID>
<DateRevised>
<Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1522-9645</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>46</Issue>
<PubDate>
<Year>2020</Year>
<Month>Dec</Month>
<Day>07</Day>
</PubDate>
</JournalIssue>
<Title>European heart journal</Title>
<ISOAbbreviation>Eur Heart J</ISOAbbreviation>
</Journal>
<ArticleTitle>The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.</ArticleTitle>
<Pagination>
<MedlinePgn>4389-4390</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehaa935</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liuzzo</LastName>
<ForeName>Giovanna</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Patrono</LastName>
<ForeName>Carlo</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Eur Heart J</MedlineTA>
<NlmUniqueID>8006263</NlmUniqueID>
<ISSNLinking>0195-668X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>10</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>10</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>11</Month>
<Day>21</Day>
<Hour>8</Hour>
<Minute>33</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33219663</ArticleId>
<ArticleId IdType="pii">5997448</ArticleId>
<ArticleId IdType="doi">10.1093/eurheartj/ehaa935</ArticleId>
<ArticleId IdType="pmc">PMC7717256</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2020 Jul 21;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32706531</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Nov 19;383(21):2030-2040</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33031652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Aug;56(2):106020</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32405156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Nov 19;383(21):2041-2052</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32706953</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000794 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000794 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33219663
   |texte=   The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33219663" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021